Amyloid-beta and tau protein beyond Alzheimer’s disease

The aggregation of amyloid-beta peptide and tau protein dysregulation are implicated to play key roles in Alzheimer’s disease pathogenesis and are considered the main pathological hallmarks of this devastating disease. Physiologically, these two proteins are produced and expressed within the normal...

Full description

Bibliographic Details
Main Authors: Morteza Abyadeh, Vivek Gupta, Joao A Paulo, Arezoo Gohari Mahmoudabad, Sina Shadfar, Shahab Mirshahvaladi, Veer Gupta, Christine T O. Nguyen, David I Finkelstein, Yuyi You, Paul A Haynes, Ghasem H Salekdeh, Stuart L Graham, Mehdi Mirzaei
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=6;spage=1262;epage=1276;aulast=Abyadeh
_version_ 1797231780203331584
author Morteza Abyadeh
Vivek Gupta
Joao A Paulo
Arezoo Gohari Mahmoudabad
Sina Shadfar
Shahab Mirshahvaladi
Veer Gupta
Christine T O. Nguyen
David I Finkelstein
Yuyi You
Paul A Haynes
Ghasem H Salekdeh
Stuart L Graham
Mehdi Mirzaei
author_facet Morteza Abyadeh
Vivek Gupta
Joao A Paulo
Arezoo Gohari Mahmoudabad
Sina Shadfar
Shahab Mirshahvaladi
Veer Gupta
Christine T O. Nguyen
David I Finkelstein
Yuyi You
Paul A Haynes
Ghasem H Salekdeh
Stuart L Graham
Mehdi Mirzaei
author_sort Morteza Abyadeh
collection DOAJ
description The aggregation of amyloid-beta peptide and tau protein dysregulation are implicated to play key roles in Alzheimer’s disease pathogenesis and are considered the main pathological hallmarks of this devastating disease. Physiologically, these two proteins are produced and expressed within the normal human body. However, under pathological conditions, abnormal expression, post-translational modifications, conformational changes, and truncation can make these proteins prone to aggregation, triggering specific disease-related cascades. Recent studies have indicated associations between aberrant behavior of amyloid-beta and tau proteins and various neurological diseases, such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, as well as retinal neurodegenerative diseases like Glaucoma and age-related macular degeneration. Additionally, these proteins have been linked to cardiovascular disease, cancer, traumatic brain injury, and diabetes, which are all leading causes of morbidity and mortality. In this comprehensive review, we provide an overview of the connections between amyloid-beta and tau proteins and a spectrum of disorders.
first_indexed 2024-04-24T15:49:49Z
format Article
id doaj.art-f8fe9e44ce7e49208ce6a071ba24f39c
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-04-24T15:49:49Z
publishDate 2024-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-f8fe9e44ce7e49208ce6a071ba24f39c2024-04-01T13:05:59ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742024-01-011961262127610.4103/1673-5374.386406Amyloid-beta and tau protein beyond Alzheimer’s diseaseMorteza AbyadehVivek GuptaJoao A PauloArezoo Gohari MahmoudabadSina ShadfarShahab MirshahvaladiVeer GuptaChristine T O. NguyenDavid I FinkelsteinYuyi YouPaul A HaynesGhasem H SalekdehStuart L GrahamMehdi MirzaeiThe aggregation of amyloid-beta peptide and tau protein dysregulation are implicated to play key roles in Alzheimer’s disease pathogenesis and are considered the main pathological hallmarks of this devastating disease. Physiologically, these two proteins are produced and expressed within the normal human body. However, under pathological conditions, abnormal expression, post-translational modifications, conformational changes, and truncation can make these proteins prone to aggregation, triggering specific disease-related cascades. Recent studies have indicated associations between aberrant behavior of amyloid-beta and tau proteins and various neurological diseases, such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, as well as retinal neurodegenerative diseases like Glaucoma and age-related macular degeneration. Additionally, these proteins have been linked to cardiovascular disease, cancer, traumatic brain injury, and diabetes, which are all leading causes of morbidity and mortality. In this comprehensive review, we provide an overview of the connections between amyloid-beta and tau proteins and a spectrum of disorders.http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=6;spage=1262;epage=1276;aulast=Abyadehamyloid-beta; cancer; cardiovascular diseases; diabetes; neurodegeneration; tau; traumatic brain injury
spellingShingle Morteza Abyadeh
Vivek Gupta
Joao A Paulo
Arezoo Gohari Mahmoudabad
Sina Shadfar
Shahab Mirshahvaladi
Veer Gupta
Christine T O. Nguyen
David I Finkelstein
Yuyi You
Paul A Haynes
Ghasem H Salekdeh
Stuart L Graham
Mehdi Mirzaei
Amyloid-beta and tau protein beyond Alzheimer’s disease
Neural Regeneration Research
amyloid-beta; cancer; cardiovascular diseases; diabetes; neurodegeneration; tau; traumatic brain injury
title Amyloid-beta and tau protein beyond Alzheimer’s disease
title_full Amyloid-beta and tau protein beyond Alzheimer’s disease
title_fullStr Amyloid-beta and tau protein beyond Alzheimer’s disease
title_full_unstemmed Amyloid-beta and tau protein beyond Alzheimer’s disease
title_short Amyloid-beta and tau protein beyond Alzheimer’s disease
title_sort amyloid beta and tau protein beyond alzheimer s disease
topic amyloid-beta; cancer; cardiovascular diseases; diabetes; neurodegeneration; tau; traumatic brain injury
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=6;spage=1262;epage=1276;aulast=Abyadeh
work_keys_str_mv AT mortezaabyadeh amyloidbetaandtauproteinbeyondalzheimersdisease
AT vivekgupta amyloidbetaandtauproteinbeyondalzheimersdisease
AT joaoapaulo amyloidbetaandtauproteinbeyondalzheimersdisease
AT arezoogoharimahmoudabad amyloidbetaandtauproteinbeyondalzheimersdisease
AT sinashadfar amyloidbetaandtauproteinbeyondalzheimersdisease
AT shahabmirshahvaladi amyloidbetaandtauproteinbeyondalzheimersdisease
AT veergupta amyloidbetaandtauproteinbeyondalzheimersdisease
AT christinetonguyen amyloidbetaandtauproteinbeyondalzheimersdisease
AT davidifinkelstein amyloidbetaandtauproteinbeyondalzheimersdisease
AT yuyiyou amyloidbetaandtauproteinbeyondalzheimersdisease
AT paulahaynes amyloidbetaandtauproteinbeyondalzheimersdisease
AT ghasemhsalekdeh amyloidbetaandtauproteinbeyondalzheimersdisease
AT stuartlgraham amyloidbetaandtauproteinbeyondalzheimersdisease
AT mehdimirzaei amyloidbetaandtauproteinbeyondalzheimersdisease